Experiments with truncated and frame-shift analogues of CLIP showed that for effective binding to class II, the sequence element CLIP90-100 must be incorporated into a peptide of 13 or more residues including at least three residues N-terminal to this motif. Additionally, it appears that different I-A molecules accommodate CLIP in different binding frames. These investigations of the relationship between the structure and binding of CLIP analogues lead us to propose that there is a general backbone motif of a periodic nature within the CLIP sequence that minimizes deleterious contacts and allows promiscuous binding to class II molecules.
Introduction
The role of the monomorphic protein invariant chain (Ii) in the molecules commonly yields a nested set of Ii peptides (7) (8) (9) (10) (11) (12) . These 'CLIP' (class II-associated Ii peptides) are derived pathway of MHC class II antigen processing and presentation is clearly one of significance (1, 2) . Acting as a molecular almost exclusively from the exon 3 region of Ii (residues 82-107), the same Ii moiety believed to be responsible for chaperone, this transmembrane glycoprotein escorts the newly assembled αβ class II complexes from the endoplasmic interaction of Ii with the class II molecule (13, 14) . The ability of CLIP to compete with antigenic peptide for binding to reticulum into the endosomal system, by virtue of a localization signal mapped to the N-terminal cytoplasmic domain (3) .
various class II molecules has been well established (15-19). However, the exact nature of the binding of CLIP is clearly During this manoeuvre, the interaction of Ii with the αβ complex serves to prevent premature association of antigenic peptide different for each member of the polymorphic MHC class II family. Perhaps the most intriguing example of this differential (4, 5) . Once the complex reaches the acidic environment of the endosomes, Ii is proteolytically degraded and dissociates CLIP binding comes from the studies of Bangia and Watts (18), where it was shown that while various I-A molecules leaving the class II binding site available for binding antigenic peptide (6) .
were able to bind CLIP at both pH 7 and pH 5, the I-E molecules only bound CLIP at pH 5. Acid elution of naturally processed peptides from class II Previously, we have determined the contribution of specific Methods CLIP side chains to binding by I-A molecules using a serial Cell lines and culture conditions set of CLIP86-104 analogues in which single amino acids Murine B cell lines A20 (I-A d ), CH27 (I-A k ), M12.D and 1-5.4 were substituted at each position by L-alanine (15) . In most [the latter two derived from M12.C3 (22) transfected with cases, these single side chain substitutions either had very cDNA encoding I-A d or I-A u α and β chains respectively] little effect on CLIP binding to I-A or increased the binding were used as antigen-presenting cells (APC). Antigen was affinity. These results suggest that particular side chains may presented to the appropriate peptide-specific T cell play an inhibitory role in CLIP binding to I-A molecules, hybridoma, 3DO.548 [ovalbumin (OVA) 323-339-specific, Ialthough they generally do not have roles as anchor residues.
A Peptides were synthesized by the ANU Biomolecular be consistent with empirical data for both human DR and
Resource Facility using standard t-butoxycarbonyl chemistry mouse I-A molecules, and with structural data from the and purified by reversed-phase HPLC to achieve a purity recent X-ray crystallographic analysis of an HLA-DR3-CLIP of Ͼ99%. Structure and purity were confirmed by mass complex (21) .
spectroscopy. Crystallographic data have resolved in exquisite detail how the binding of CLIP to DR3 occurs within the antigenic T cell hybridoma assay peptide-binding site (21) . This information may serve as a Peptide-specific T cell hybridomas (2.5ϫ10 4 ) were co-incubpoint of reference for extrapolation to the many possible ated with APC (2.5ϫ10 4 ), a sub-optimal dose of antigenic interactions between CLIP and different class II molecules.
peptide and a dilution series of competitor CLIP. After 24 h, This is realistic since the majority of amino acids in the class 50 ml of supernatant was harvested from each well and tested II binding groove are largely conserved, despite extensive for IL-2 activity using the IL-2-dependent cell line, HT-2. polymorphism in defined regions. Nonetheless, it is not trivial Proliferation of HT-2 was measured from [ 3 H]thymidine incorpto deduce from a sole static crystal structure, the dynamic oration as previously described (23). biochemical properties of the interaction of a single ligand Cell surface peptide binding assay which binds promiscuously to many homologous heterodimCell surface binding assays were performed essentially as eric macromolecules. Thus, empirical data remain essential previously described (23,24). Day to day variations between in order to verify theoretical conclusions. experiments may occur due to the nature of this technique, Our aim in this study was to examine the binding determinrelated to subtle differences in culture conditions and their ants of CLIP to several I-A MHC class II molecules in order subsequent effects on levels of class II expression. Briefly, to determine if CLIP adopt a constrained backbone conforma-APC (1ϫ10 5 ) in normal culture medium were co-incubated tional structure which allows general binding. To achieve this for 18-20 h with biotinylated CLIP86-104 peptide and a we have synthesized a serial set of peptides with D-alanine dilution series of competitor CLIP. Cells were washed in PBS configurational substitutions within the CLIP86-104 sequence containing 0.1% BSA and 0.05% sodium azide, then stained and sets of truncated CLIP. In this way we demonstrate that with FITC-streptavidin (Pierce, Rockford, IL) at 4°C for 1 h. stereochemical disruption of secondary structure only in the Incubation was followed by two further washes in the PBS phylogenetically conserved region of CLIP (residues 91-99) medium and stained cells were then subjected to flow cytomeleads to abrogation of CLIP binding to various I-A class II try on a FACScan (Becton Dickinson, Mountain View, CA). To molecules. Truncated and frame-shifted sets of peptides of measure the relative amount of fluoresceinated streptavidin the CLIP sequence have revealed that, unlike antigen-derived bound, the median fluorescence of 10,000 propidium iodidepeptides, CLIP bind very poorly once the length is reduced negative cells was determined. IC 50 values were calculated to Ͻ13 amino acids. In addition, the effective binding of for each peptide competitor. CLIP86-104 to most I-A molecules requires at least two to three residues N-terminal to the 91-99 segment. 
Examination of the binding of side-chain-substituted CLIP D-Ala 87 (P):
e. with L-alanine) to different I-A haplotypes revealed the
effect of allelic polymorphism (15). Similarly, Sette et al. (17) D-Ala 89 (S):
have shown the effect of allelic polymorphism in both mouse
and human class II molecules upon binding CLIP. The compar-
ative binding of stereochemically substituted CLIP86-104
analogues reported herein reveals slight differences between D-Ala 94 (A):
the three I-A haplotypes tested. Close examination of the data D-Ala 96 (P):
single native residues are substituted with D-alanine from the
N-terminus towards the C-terminus. The ability of CLIP to
compete with MBP Ac1-11 for antigen presentation by I-A u
molecules is almost completely abrogated if the residues D-Ala 103 (S):
between glutamine at position 90 (Q90) and proline 101 with a serial set of L-alanine-substituted CLIP peptides disclass II molecules. Given that side chain substitutions were played no such patterns (15). generally without significant effect, we directly examined the The contribution of I-E-CLIP interactions in this study specific effect of backbone stereochemistry on the CLIPfrom the I-E k and I-E d class II molecules expressed on the class II interaction. To this end, peptides with single D-alanine cell surface of the cell lines CH27 and A20 respectively is amino acid substitutions in CLIP86-104 were synthesized believed to be minimal using this assay method. Firstly, the ( Table 1 ). The ability of these peptides to compete with transfectant B cell line, M12.D, expressing only I-A d class antigenic peptides for antigen presentation in T cell hybridoma II molecules shows an identical pattern of results to those assays was determined ( Fig. 1 ) and compared with that of achieved with the A20 cell line (data not shown). Secondly, the L-alanine-substituted CLIP (15). A striking feature in these those results in turn correlate with the findings for 1-5.4 assays was the loss of competitive ability when D-alanine which expresses only I-A u class II molecules (23). Lastly, substitutions fell in the central region of the peptide (Fig. 1) competition by CLIP86-104 with the hen egg lysozyme (approximately between residues 91 and 99 allowing for peptide HEL105-120 for presentation to an I-E k -restricted haplotypic differences). This trend was not apparent in the T cell hybridoma, is barely detectable under these conditions previously published assay series of the L-alanine-substituted (our unpublished results). peptides (15), indicating that specific side chains do not Competition for antigen presentation by CLIP analogues essentially contribute to the major positive binding deteras discussed above is a useful way to determine binding minant.
propensity for MHC class II molecules in a whole cell Interestingly, substitution of the two to three native Nmodel (7, 15) . To elucidate the interaction of CLIP to I-A terminal CLIP residues with D-alanine was shown to increase molecules more precisely, CLIP analogues may be used to the ability of CLIP86-104 to compete for antigen presentation compete with more than one antigen-derived peptide in a by I-A u and I-A d and, to a lesser extent, by I-A k . By comparison, T cell hybridoma assay for each I-A haplotype. Additionally, substitution of the last three C-terminal native residues has given that CLIP86-104 binds to a number of I-A molecules not such a marked effect on CLIP binding. It is possible that albeit with varying affinities, it is useful to have an assay the native N-terminal residues in CLIP reduce binding affinity system in which CLIP analogues compete directly with the such that CLIP is readily released when the class II molecules wild-type CLIP to provide more quantitative analysis. By encounter potential antigen-derived peptides in the acidic using biotinylated CLIP86-104 peptide in a flow cytometryendosomal compartments. This issue is currently the subject based cell surface peptide binding assay (23,24), a direct of further investigations. Alternatively, the apparent increased comparison between CLIP analogues and their ability to binding observed for the N-terminal-substituted peptides may bind I-A molecules can be determined relative to the wildtype peptide (Fig. 2) . Data is presented as the level of be merely artificial in an in vivo experiment resulting from to the I-E k molecules expressed by the CH27 cells (our unpublished results). these I-A haplotypes (Fig. 2) . The binding pattern observed with this assay (Fig. 2) closely resembles that seen in the CLIP sequences truncated to Ͻ13 residues bind poorly to competitive T cell hybridoma assays (Fig. 1) arguing again class II for the importance of the central CLIP core determinant in binding to the I-A class II molecules tested. Negligible Binding data obtained from peptides with D-alanine substitutions in CLIP86-104 suggested that any such changes in the contributions to CLIP binding by the I-E molecules expressed by the A20 and CH27 cell lines were again assumed middle of the peptide abrogated binding to I-A molecules. To The ability of the intermediate length truncated peptides to for binding to I-A molecules, a set of truncated peptides were synthesized in which residues were sequentially removed compete better makes it interesting to speculate that should such a peptide occur in vivo, then the efficient displacement pairwise from each. These truncated peptides were then examined for their binding ability to I-A molecules using the of CLIP in the endosomes would be impaired. Fortunately such peptides are probably rarely generated in vivo in any competitive cell surface binding assay ( Table 2 ). The shorter CLIP87-103 consistently competes better than CLIP86-104 great abundance, given the protection from endopeptidases afforded by binding within the peptide-binding groove (25), for cell surface binding to I-A u and I-A k molecules, suggesting that a shorter CLIP has a higher affinity for two of the three Icombined with the inefficient degradation by exopeptidases of peptides with proline residues close to their N-terminus A molecules tested. However, when the length of CLIP was truncated to 13 amino acids or below, the ability of these (26). Nevertheless, Chicz et al. (10) have reported eluting a similar N-terminal truncated CLIP that binds with high affinity peptides to compete for binding was greatly reduced. This is best illustrated by the inability to detect any binding of to HLA-DR1 molecules. Regardless, there is clearly a minimum Competition by truncated CLIP for binding to I-A class II molecules. CLIP from which residues were sequentially removed from each end were tested at multiple doses as competitors against biotinylated CLIP86-104 (50 µM) in a cell surface binding assay (see Methods). Background levels of 3.54, 5.14 and 3. length requirement of 13 amino acids for CLIP to bind the haplotypes tested. It is interesting to note that the similarity of amino acid sequence between I-A u and I-A k is greater than efficiently to I-A class II molecules (Table 2 ). This is an interesting result in light of the findings of Malcherek et al. that between either of these and I-A d (27) This is reflected in the data presented here wherein I-A u and I-A k display binding (16) who have determined that a sequence of 13 amino acids is still sufficient for excellent binding of CLIP to DR17 and DR1. patterns with CLIP analogues more similar to each other than that seen with I-A d (see Fig. 2 , and Tables 2 and 3 ). In Consistent with our other observations (Fig. 1) , certain haplotypic differences were observed in the binding of these addition, these data also suggest that the N-terminal portion of CLIP may also be important in its normal binding to class truncated peptides to class II molecules. In particular, the binding of CLIP86-104 to I-A d appears to be more highly II molecules as is the case for DR molecules (28,29). dependent on the CLIP length than the CLIP binding to either I-A u or I-A k . The physiological importance of such a difference Discussion in CLIP binding is not yet understood; however. it is conceivable that the preferential positive binding motif may differ in
In this study we have attempted to provide explanations as to how CLIP is able to bind most MHC class II molecules. By length due to positive interactions being offset by deleterious contacts when CLIP occupies the peptide-binding groove of using a number of stereochemically modified and truncated CLIP analogues, we have been able to demonstrate a general different class II molecules. mode of binding to three different I-A class II molecules. The positive binding determinant in CLIP86-104 for different Binding occurs by virtue of an essentially common segment I-A molecules appears to be in slightly different frames.
based around a central continuous backbone motif, which appears to adopt a constrained conformation involving the The minimum length within the native CLIP sequence which bound efficiently to class II and competed well with antigenic highly conserved residues 91-99. These are the same CLIP residues that have been shown to occupy the binding groove peptide was 15 residues (Table 2 ). This raised the question of whether any 15 residue CLIP sequence including 91-99 of the recently crystallized HLA-DR3 class II molecules (21) . We have shown that any configurational change within this would bind to I-A molecules or whether specific flanking residues are important also. In order to examine the binding region of CLIP abrogates binding to I-A class II, whereas many side chain substitutions are tolerated (15). Additionally, determinants more precisely and also to examine how polymorphism within various I-A molecules may affect these, a for optimal binding three residues N-terminal to this segment are required. Interestingly, it appears from these results that set of 15 residue peptides was synthesized with a single amino acid frame shift from 86-100 to 90-104 (Table 3 ). All the preferred manner in which each I-A haplotype accommodates CLIP in the binding site differs slightly. In particular, it of these peptides incorporated the essential residues 91-99. Examination of these peptides using the competitive cell seems that the positive binding determinant for various I-A molecules may be in different register (Table 3) . surface binding assay revealed that overall, those peptides containing all or part of the original N-terminal sequence Classically, the peptide binding motif for class II molecules displays minimal structural constraints. A significant factor for (CLIP86-100, 87-101 and 88-102) consistently competed better for class II binding than those containing intact Cselection of suitable peptides for binding to class II is the avoidance of deleterious contacts (30,31). The ability of terminal residues (CLIP89-103 and 90-104). Once again, despite general similarities, there were haplotypic differences different peptides to bind degenerately to multiple MHC class II alleles is indicative of the binding site having a significant in the manner that these peptides competed for cell surface I-A binding. While CLIP88-102 competed best for I-A k binding, number of conserved features. Indeed, Malcherek et al. (16) have proposed that promiscuous peptides such as CLIP utilize CLIP87-101 competed consistently better for I-A d and I-A u binding. Although there were subtle haplotypic differences, these features to bind to HLA-DR molecules by exhibiting a 'supermotif'. The allele-specific contact sites seen in antigenic CLIP89-103 and CLIP90-104 generally competed poorly for Effect of single frameshifts in CLIP86-104 on the cell surface binding to I-A class II molecules. Fifteen residue CLIP with a single frameshift were synthesized and tested at multiple doses as competitors against biotinylated CLIP86-104 (50 µM) in a cell surface binding as described in Methods. Data is presented as mean IC 50 values (µM) from at least two independent experiments. Background levels and maximum signals of fluorescence intensity recorded for each haplotype are as in Table 2. peptides are absent within the CLIP sequence to keep note from modelling (20) and the X-ray crystallographic potential negative effects to a minimum (16, 32) . In this study, studies (21) that methionine 91, 93 and 99 interact directly the general trends apparent in the binding of numerous CLIP with the binding groove of the MHC class II molecules analogues to several MHC class II I-A molecules arise from with methionine 91 and 99 implicated as anchor residues. modifications to the peptide backbone rather than from substiHowever, our data reveal that the steric bulk of methionine tution of individual side chains. This is consistent with the 93 and 99 contributes towards efficient displacement of CLIP idea that CLIP binds promiscuously to I-A allelic variants by by antigenic peptide in competitive assays to I-A molecules adopting a conformation which both constitutes a universal (15). Likewise, Malcherek et al. (16) have determined that at positive binding determinant and synchronously minimizes least the methionine residue at CLIP99 (M115 in the human deleterious contacts of side chains with residues of the CLIP sequence) constitutes a significant negative binding peptide-binding groove.
determinant for HLA-DR molecules. By contrast, these authors Lee and McConnell (20) have predicted that bound CLIP reported that residue 91 (human CLIP M107) serves as an will assume the same conformation as that adopted by important anchor residue for binding to HLA-DR molecules. antigenic peptides. This has been borne out in the comparison
We have found that M91 fits this role in the case of I-A k but of an HLA-DR3-CLIP complex (21) with that of HLA-DR1 not for I-A d or I-A u class II molecules (15). complexed with the influenza virus haemagglutinin peptide Caution must be exercised when comparing the CLIP HA306-318 (30), where crystallographic analysis has supermotif proposed for binding to HLA-DR alleles with that revealed both peptides adopt a polyproline type II helix. Stern for binding to I-A alleles. The outer amino terminal domain of et al. (30) have previously suggested that many peptides the DRα chain which contributes significantly to the construcmay share a common conformation when bound to class II tion of the peptide-binding groove is unique in class II proteins irrespective of the conformation that a particular molecules for its minimal allelic polymorphism (31). It is thus sequence may adopt in the progenitor protein. This helical more appropriate for the DR-binding CLIP supermotif to be arrangement results in the outward projection of backbone compared with that of the murine homologue I-E. Studies of amide protons and carbonyl oxygen atoms and also side this nature are currently underway and should prove intereschains, and has a higher probability of forming intermolecular ting in light of recent reports of little or no association of Ii hydrogen bonds in the binding groove than an extended β-peptides with various I-E haplotypes at pH 7.0 (7,17,18; our conformation. Additionally, if there were no accommodating unpublished results). binding pocket, then the probability of projecting every second
The existence of a general structural motif in CLIP that and third side chain out of the groove in this conformation is minimizes deleterious contacts with residues of the peptideenhanced also. By contrast, only alternate side chains could binding groove and allows promiscuous binding to class project in a peptide bound in an extended β-strand-like II may be fundamentally important for antigen-processing conformation, thus increasing the overall probability of steric pathways, for example its dissociation by DM molecules (33-repulsion and, additionally, reducing the probability of favour-37). In this scenario, CLIP are associated with polymorphic able backbone contacts. The empirical data presented here class II to form a complex which is recognized by monocompliment the theoretical models for I-A of Lee and morphic DM molecules but remains distinguishable from McConnell (20) and X-ray crystallographic data for DR3
antigen-derived peptide-class II complexes. Yet while it is molecules (21) . If CLIP bind in a pseudo polyproline II now accepted that the CLIP sequence is the region of Ii conformation, substitutions by D-alanine between residues responsible for binding to class II and blocking peptide should disrupt this conformation and prevent binding. Simbinding (14-20,38), it remains to be determined if the CLIP ilarly, one would predict a periodic pattern in side chain core sequence (murine 87-110) within the native Ii is able to interaction where substitution of every third and/or fourth reach the peptide binding groove as has been suggested residue affects binding. This pattern was indeed visible for (1, 12, 13) . The number of biochemical similarities described the I-A haplotypes screened when native CLIP residues were singly substituted with L-alanine (15). It is also interesting to between CLIP and intact Ii for binding to class II (1, 2, 39) histocompatibility complex class II molecules contains the make it persuasive to speculate that such an interaction does sequence of a peptide eluted from class II polypeptides. Proc. take place.
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